Corcept Therapeutics (CORT) is down -48.7%, or -$34.19 to $36.01.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CORT:
- Corcept downgraded to Underperform at Wolfe after CRL for relacorilant
- Corcept Therapeutics downgraded to Underperform from Peer Perform at Wolfe Research
- Why Is Corcept Therapeutics Stock (CORT) Down Today?
- Morning Movers: Nvidia up as report points to strong demand in China
- Corcept Therapeutics down 40% to $42.16 after receiving CRL for relacorilant